Cortexyme (CRTX) News Today

$1.06
+0.01 (+0.95%)
(As of 04/22/2024 ET)
SourceHeadline
marketscreener.com logoCortexyme : Quince Therapeutics Details Strategic Growth Plan with Launch of New Corporate Name - Form 8-K - Marketscreener.com
marketscreener.com - August 1 at 11:24 AM
marketscreener.com logoCortexyme Completes Phase 1 Single, Multiple Ascending Dose Trial of Potential Alzheimer's Disease Treatment - Marketscreener.com
marketscreener.com - July 27 at 3:47 PM
businesswire.com logoCortexyme Corporate Name Change to Quince Therapeutics to Take Effect on August 1, 2022 - Business Wire
businesswire.com - July 27 at 3:47 PM
businesswire.com logoCortexyme Successfully Completes Phase 1 Single and Multiple Ascending Dose Clinical Trial of COR588 - Business Wire
businesswire.com - July 27 at 3:47 PM
marketscreener.com logoCortexyme Corporate Name Change to Quince Therapeutics to Take Effect on August 1, 2022 - Marketscreener.com
marketscreener.com - July 27 at 10:45 AM
finance.yahoo.com logoCortexyme Successfully Completes Phase 1 Single and Multiple Ascending Dose Clinical Trial of COR588 - Yahoo Finance
finance.yahoo.com - July 27 at 10:45 AM
finance.yahoo.com logoCortexyme Successfully Completes Phase 1 Single and Multiple Ascending Dose Clinical Trial of COR588
finance.yahoo.com - July 27 at 10:44 AM
finance.yahoo.com logoCortexyme Corporate Name Change to Quince Therapeutics to Take Effect on August 1, 2022
finance.yahoo.com - July 27 at 10:44 AM
streetinsider.com logoCortexyme (CRTX) Announces Resignation of EVP of Research and Development - StreetInsider.com
streetinsider.com - July 22 at 10:41 PM
gurufocus.com logoBragar Eagel & Squire, PC Is Investigating Agrify, CareDx, Medallion, and Cortexyme and Encourages Investors to Contact the Firm - GuruFocus.com
gurufocus.com - June 26 at 2:17 AM
benzinga.com logoCortexyme Announces Preclinical Data Demonstrating Efficacy Of Cor803 For The Treatment Of Coronavirus In - Benzinga
benzinga.com - June 21 at 11:52 AM
nasdaq.com logoCortexyme : Preclinical Data Show Efficacy Of COR803 For Coronavirus Infections Treatment - Nasdaq
nasdaq.com - June 21 at 11:52 AM
finance.yahoo.com logoCortexyme Announces Preclinical Data Demonstrating Efficacy of COR803 for the Treatment of Coronavirus Infections
finance.yahoo.com - June 21 at 11:52 AM
businesswire.com logoCortexyme Appoints June Bray to its Board of Directors - Business Wire
businesswire.com - June 13 at 3:34 PM
finance.yahoo.com logoCortexyme Appoints June Bray to its Board of Directors - Yahoo Finance
finance.yahoo.com - June 13 at 10:33 AM
finance.yahoo.com logoCortexyme Appoints June Bray to its Board of Directors
finance.yahoo.com - June 13 at 10:33 AM
marketscreener.com logoCortexyme, Inc. Announces Resignation of Christopher Lowe as Chief Financial Officer - Marketscreener.com
marketscreener.com - June 11 at 12:50 PM
marketscreener.com logoCortexyme : Statement of Changes in Beneficial Ownership (Form 4) - Marketscreener.com
marketscreener.com - June 10 at 4:48 PM
businesswire.com logoCortexyme Successfully Completes Acquisition of Novosteo - Business Wire
businesswire.com - May 22 at 5:27 PM
nasdaq.com logoThis Is the Worst Type of Credit Card for Most Consumers - Nasdaq
nasdaq.com - May 20 at 5:28 PM
finance.yahoo.com logoPPG Showcases Innovations in Paints, Coatings, Specialty Materials That Enhance Sustainability, Efficiency, Mobility - Yahoo Finance
finance.yahoo.com - May 20 at 9:21 AM
marketscreener.com logoCortexyme : Completion of Acquisition or Disposition of Assets - Form 8-K - Marketscreener.com
marketscreener.com - May 20 at 9:21 AM
finance.yahoo.com logoCortexyme Successfully Completes Acquisition of Novosteo - Yahoo Finance
finance.yahoo.com - May 20 at 9:21 AM
finance.yahoo.com logoCortexyme Appoints Dr. Philip Low to Its Board of Directors
finance.yahoo.com - May 20 at 9:21 AM
nasdaq.com logoPre-market Movers: EBET, AFRM, CELU, FIGS, LLAP… - Nasdaq
nasdaq.com - May 13 at 3:32 PM
finance.yahoo.com logoCortexyme to Participate at 4th International Conference on Porphyromonas gingivalis and Related Species in Oral and Systemic Diseases - Yahoo Finance
finance.yahoo.com - May 12 at 10:14 AM
finance.yahoo.com logoCortexyme to Participate at 4th International Conference on Porphyromonas gingivalis and Related Species in Oral and Systemic Diseases
finance.yahoo.com - May 12 at 10:14 AM
streetinsider.com logoForm 10-Q Cortexyme, Inc. For: Mar 31 - StreetInsider.com
streetinsider.com - May 11 at 1:09 AM
streetinsider.com logoCortexyme Announces Agreement to Acquire Novosteo - StreetInsider.com
streetinsider.com - May 11 at 1:09 AM
bizjournals.com logoTuesday Digest: Prologis attempts hostile buyout of Duke; Salesforce's latest buy - San Francisco Business Times - The Business Journals
bizjournals.com - May 10 at 2:57 PM
finance.yahoo.com logoCortexyme Announces Agreement to Acquire Novosteo
finance.yahoo.com - May 10 at 9:56 AM
benzinga.com logoBragar Eagel & Squire, P.C. Is Investigating Agrify, CareDx, Medallion, and Cortexyme and Encourages Investors to Contact the Firm
benzinga.com - May 6 at 9:43 PM
finance.yahoo.com logoIs Cortexyme (NASDAQ:CRTX) In A Good Position To Deliver On Growth Plans?
finance.yahoo.com - May 6 at 3:29 PM
gurufocus.com logoBragar Eagel & Squire, PC Is Investigating CareDx, Medallion, Cortexyme, and Corcept and Encourages Investors to Contact the Firm - GuruFocus.com
gurufocus.com - May 3 at 11:39 PM
benzinga.com logoThe Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Appl - Benzinga
benzinga.com - May 3 at 1:35 PM
benzinga.com logoCortexyme Announces Further Layoffs, Chief Medical Officer Leaves
benzinga.com - May 3 at 10:17 AM
marketscreener.com logoCORTEXYME, INC. : Costs Associated with Exit or Disposal Activities, Change in Directors or Principal Officers (form 8-K) - Marketscreener.com
marketscreener.com - May 3 at 1:08 AM
benzinga.com logoBragar Eagel & Squire, P.C. Is Investigating CareDx, Medallion, Cortexyme, and Corcept and Encourages Investors to Contact the Firm
benzinga.com - May 1 at 9:38 PM
benzinga.com logoCortexyme, Inc. Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - Benzinga
benzinga.com - April 28 at 1:44 PM
benzinga.com logoBragar Eagel & Squire, P.C. Is Investigating Cortexyme, Corcept, RBB, and Verra and Encourages Investors to Contact the Firm
benzinga.com - April 25 at 9:12 PM
prnewswire.com logoThinking about buying stock in Cortexyme, Borqs Technologies, Sundial Growers, Nokia, or Nordic American Tanker? - PR Newswire
prnewswire.com - April 25 at 3:19 PM
benzinga.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cortexyme, Inc. - CRTX - Benzinga
benzinga.com - April 23 at 9:08 PM
benzinga.com logoBragar Eagel & Squire, P.C. Is Investigating CareDx, Medallion, Cortexyme, and SelectQuote and Encourages Investors to Contact the Firm
benzinga.com - April 15 at 9:28 PM
globenewswire.com logoBragar Eagel & Squire, PC Is Investigating CareDx, Medallion, Cortexyme, and SelectQuote and Encourages Investors to Contact the Firm - GlobeNewswire
globenewswire.com - April 15 at 9:03 PM
benzinga.com logoBragar Eagel & Squire, P.C. Is Investigating Medallion, Cortexyme, SelectQuote, and Corcept and Encourage - Benzinga
benzinga.com - April 11 at 10:31 AM
globenewswire.com logoBragar Eagel & Squire, PC Is Investigating Medallion, - GlobeNewswire
globenewswire.com - April 10 at 11:33 PM
marketbeat.com logoCortexyme (NASDAQ:CRTX) Downgraded to "Sell" at Zacks Investment Research
marketbeat.com - March 29 at 8:15 PM
globenewswire.com logoHAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Investigating Cortexyme, Inc. (CRTX) For Possible Securities Law Violations, Encourages Investors With Significant Losses to Contact Firm - GlobeNewswire
globenewswire.com - March 28 at 6:26 PM
globenewswire.com logoBragar Eagel & Squire, PC Is Investigating Sea, - GlobeNewswire
globenewswire.com - March 27 at 12:11 PM
benzinga.com logoBragar Eagel & Squire, P.C. Is Investigating Sea, Cortexyme, and RBB and Encourages Investors to Contact the Firm
benzinga.com - March 25 at 9:49 PM
Get Cortexyme News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRTX and its competitors with MarketBeat's FREE daily newsletter.

SHOCKING Crypto Leak… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

CRTX Media Mentions By Week

CRTX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CRTX
News Sentiment

0.00

0.46

Average
Medical
News Sentiment

CRTX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CRTX Articles
This Week

0

0

CRTX Articles
Average Week

Get Cortexyme News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRTX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:CRTX) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners